MARKET

VTAK

VTAK

Catheter Precision
AMEX
0.2970
+0.0031
+1.05%
Opening 10:21 05/13 EDT
OPEN
0.2901
PREV CLOSE
0.2939
HIGH
0.3318
LOW
0.2820
VOLUME
283.24K
TURNOVER
--
52 WEEK HIGH
8.40
52 WEEK LOW
0.2400
MARKET CAP
2.75M
P/E (TTM)
-0.0445
1D
5D
1M
3M
1Y
5Y
1D
Catheter Precision announces $1.5M private placement equity financing
TipRanks · 15h ago
Weekly Report: what happened at VTAK last week (0505-0509)?
Weekly Report · 1d ago
Catheter Precision Finalizes Strategic Cardiac Acquisition
TipRanks · 4d ago
Weekly Report: what happened at VTAK last week (0428-0502)?
Weekly Report · 05/05 10:12
Catheter Precision announces clinical data about VIVO to be presented
TipRanks · 05/01 12:23
Weekly Report: what happened at VTAK last week (0421-0425)?
Weekly Report · 04/28 10:17
Key deals this week: Ant Group, Boeing, EQT, Calibre Mining and more
Seeking Alpha · 04/26 19:15
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 04/24 17:05
More
About VTAK
More
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Recently
Symbol
Price
%Change

Webull offers Catheter Precision Inc stock information, including AMEX: VTAK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTAK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTAK stock methods without spending real money on the virtual paper trading platform.